Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 123

1.

Correcting the NLRP3 inflammasome deficiency in macrophages from autoimmune NZB mice with exon skipping antisense oligonucleotides.

Thygesen SJ, Sester DP, Cridland SO, Wilton SD, Stacey KJ.

Immunol Cell Biol. 2016 Feb 2. doi: 10.1038/icb.2016.3. [Epub ahead of print]

PMID:
26833024
2.

Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.

Toh ZY, Thandar Aung-Htut M, Pinniger G, Adams AM, Krishnaswarmy S, Wong BL, Fletcher S, Wilton SD.

PLoS One. 2016 Jan 8;11(1):e0145620. doi: 10.1371/journal.pone.0145620. eCollection 2016.

3.

A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma.

Stirnweiss A, McCarthy K, Oommen J, Crook ML, Hardy K, Kees UR, Wilton SD, Anazodo A, Beesley AH.

Oncogenesis. 2015 Nov 9;4:e174. doi: 10.1038/oncsis.2015.33.

4.

Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient.

Greer K, Mizzi K, Rice E, Kuster L, Barrero RA, Bellgard MI, Lynch BJ, Foley AR, O Rathallaigh E, Wilton SD, Fletcher S.

Mol Genet Genomic Med. 2015 Jul;3(4):320-6. doi: 10.1002/mgg3.144. Epub 2015 Apr 15.

5.

A Registry Framework Enabling Patient-Centred Care.

Bellgard MI, Napier K, Render L, Radochonski M, Lamont L, Graham C, Wilton SD, Fletcher S, Goldblatt J, Hunter AA, Weeramanthri T.

Stud Health Technol Inform. 2015;214:8-14.

PMID:
26210411
6.

The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow.

de la Kethulle de Ryhove L, Ansseau E, Nachtegael C, Pieters K, Vanderplanck C, Geens M, Sermon K, Wilton SD, Coppée F, Lagneaux L, Belayew A.

Stem Cells Dev. 2015 Nov 15;24(22):2674-86. doi: 10.1089/scd.2014.0575. Epub 2015 Aug 26.

PMID:
26192274
7.

The emperor's new dystrophin: finding sense in the noise.

Wilton SD, Veedu RN, Fletcher S.

Trends Mol Med. 2015 Jul;21(7):417-26. doi: 10.1016/j.molmed.2015.04.006. Epub 2015 Jun 4. Review.

PMID:
26051381
8.

Corrigendum: Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.

Wein N, Vulin A, Falzarano MS, Szigyarto CA, Maiti B, Findlay A, Heller KN, Uhlén M, Bakthavachalu B, Messina S, Vita G, Passarelli C, Brioschi S, Bovolenta M, Neri M, Gualandi F, Wilton SD, Rodino-Klapac LR, Yang L, Dunn DM, Schoenberg DR, Weiss RB, Howard MT, Ferlini A, Flanigan KM.

Nat Med. 2015 May;21(5):537. doi: 10.1038/nm0515-537c. No abstract available.

PMID:
25951531
9.

Corrigendum: Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.

Wein N, Vulin A, Falzarano MS, Szigyarto CA, Maiti B, Findlay A, Heller KN, Uhlén M, Bakthavachalu B, Messina S, Vita G, Passarelli C, Gualandi F, Wilton SD, Rodino-Klapac LR, Yang L, Dunn DM, Schoenberg DR, Weiss RB, Howard MT, Ferlini A, Flanigan KM.

Nat Med. 2015 Apr;21(4):414. doi: 10.1038/nm0415-414b. No abstract available.

PMID:
25849273
10.

Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy.

Aaldering LJ, Tayeb H, Krishnan S, Fletcher S, Wilton SD, Veedu RN.

RNA Biol. 2015;12(4):412-25. doi: 10.1080/15476286.2015.1017234. Review.

11.

Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.

Wein N, Vulin A, Falzarano MS, Szigyarto CA, Maiti B, Findlay A, Heller KN, Uhlén M, Bakthavachalu B, Messina S, Vita G, Passarelli C, Brioschi S, Bovolenta M, Neri M, Gualandi F, Wilton SD, Rodino-Klapac LR, Yang L, Dunn DM, Schoenberg DR, Weiss RB, Howard MT, Ferlini A, Flanigan KM.

Nat Med. 2014 Sep;20(9):992-1000. doi: 10.1038/nm.3628. Epub 2014 Aug 10. Erratum in: Nat Med. 2015 May;21(5):537. Brioschi, Simona [added]; Bovolenta, Matteo [added]; Neri, Marcella [added]. Nat Med. 2015 May;21(5):537. Nat Med. 2015 Apr;21(4):414.

12.

Antisense oligonucleotide induction of progerin in human myogenic cells.

Luo YB, Mitrpant C, Adams AM, Johnsen RD, Fletcher S, Mastaglia FL, Wilton SD.

PLoS One. 2014 Jun 3;9(6):e98306. doi: 10.1371/journal.pone.0098306. eCollection 2014.

13.

Dystrophin as a therapeutic biomarker: are we ignoring data from the past?

Wilton SD, Fletcher S, Flanigan KM.

Neuromuscul Disord. 2014 Jun;24(6):463-6. doi: 10.1016/j.nmd.2014.03.007. Epub 2014 Mar 22. No abstract available.

PMID:
24767581
14.

Targeted exon skipping to correct exon duplications in the dystrophin gene.

Greer KL, Lochmüller H, Flanigan K, Fletcher S, Wilton SD.

Mol Ther Nucleic Acids. 2014 Mar 18;3:e155. doi: 10.1038/mtna.2014.8.

15.

Antisense suppression of donor splice site mutations in the dystrophin gene transcript.

Fletcher S, Meloni PL, Johnsen RD, Wong BL, Muntoni F, Wilton SD.

Mol Genet Genomic Med. 2013 Sep;1(3):162-73. doi: 10.1002/mgg3.19. Epub 2013 Jun 13.

16.

Normal and aberrant splicing of LMNA.

Luo YB, Mastaglia FL, Wilton SD.

J Med Genet. 2014 Apr;51(4):215-23. doi: 10.1136/jmedgenet-2013-102119. Epub 2014 Jan 23. Review.

PMID:
24459210
17.

Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles.

Luo YB, Mitrpant C, Johnsen RD, Fabian VA, Fletcher S, Mastaglia FL, Wilton SD.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2778-86. eCollection 2013.

18.

Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse.

Luo YB, Johnsen RD, Griffiths L, Needham M, Fabian VA, Fletcher S, Wilton SD, Mastaglia FL.

Int J Exp Pathol. 2013 Dec;94(6):418-25. doi: 10.1111/iep.12048. Epub 2013 Oct 31.

19.

Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM).

Rojana-udomsart A, Mitrpant C, Bundell C, Price L, Luo YB, Fabian V, Wilton SD, Hollingsworth P, Mastaglia FL.

J Neuroimmunol. 2013 Nov 15;264(1-2):65-70. doi: 10.1016/j.jneuroim.2013.08.008. Epub 2013 Aug 30.

PMID:
24041831
20.

Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis.

Luo YB, Mitrpant C, Johnsen R, Fabian V, Needham M, Fletcher S, Wilton SD, Mastaglia FL.

Int J Clin Exp Pathol. 2013 Aug 15;6(9):1723-33. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk